Expanding HIF Prolyl Hydroxylase Inhibitors Beyond Anemia

This inventive concept explores novel applications of HIF prolyl hydroxylase inhibitors in various industries, including athletic performance, altitude sickness, cognitive function, sleep apnea, and wound healing, leveraging the core technology's potential to increase oxygen delivery and reduce fatigue.

The original patent disclosed the use of HIF prolyl hydroxylase inhibitors for treating anemia. However, the patent's scope was limited to anemia-related applications. This inventive concept addresses the problem of underutilization of HIF prolyl hydroxylase inhibitors by exploring new use cases that can benefit from the technology's oxygen-enhancing effects.

The new claims encompass various applications of HIF prolyl hydroxylase inhibitors. For instance, the inhibitors can be used to enhance athletic performance by increasing oxygen delivery to muscles, reducing fatigue, and improving endurance. In the context of altitude sickness, the inhibitors can increase hemoglobin levels and alleviate symptoms. Additionally, the inhibitors can be employed to enhance cognitive function by increasing oxygen delivery to the brain, leading to improved focus, concentration, and memory. Furthermore, the inhibitors can be used to treat sleep apnea by increasing oxygen saturation levels during sleep and reducing the frequency of apneic events. Lastly, the inhibitors can promote wound healing by increasing oxygen delivery to the wound site, thereby accelerating tissue repair and healing.

The new claims introduce novel applications of HIF prolyl hydroxylase inhibitors, which were not contemplated in the original patent. The inventive step lies in the recognition of the technology's potential to increase oxygen delivery and reduce fatigue in various contexts, beyond anemia-related applications.

Alternative embodiments of the inventive concept could include different formulations, dosing regimens, or routes of administration for the HIF prolyl hydroxylase inhibitors. Additionally, the inhibitors could be combined with other therapeutic agents or used in conjunction with lifestyle modifications to enhance their effects.

The inventive concept has significant commercial potential in various industries, including sports medicine, aerospace, neuroscience, sleep disorders, and wound care. The market for these applications is substantial, with potential users including athletes, individuals living at high altitudes, individuals with cognitive impairments, patients with sleep apnea, and individuals with chronic wounds.